annb0t
Top 20
MELBOURNE, Australia and INDIANAPOLIS, June 6, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces its presence at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting to be held in Vancouver from June 11-14. (PRNewsfoto/Telix Pharmaceuticals Limited)
Gallium-based prostate-specific membrane antigen (PSMA) imaging with positron emission tomography (PET) (PSMA-PET) will be a highlight of the meeting, where Telix is showcasi...
>>> Read more: Telix Showcasing Innovation in Theranostics at SNMMI
Gallium-based prostate-specific membrane antigen (PSMA) imaging with positron emission tomography (PET) (PSMA-PET) will be a highlight of the meeting, where Telix is showcasi...
>>> Read more: Telix Showcasing Innovation in Theranostics at SNMMI
